Latest news with #ElyseShapiro
Business Insider
29-05-2025
- Business
- Business Insider
Microba Life Sciences Limited (MAP) Receives a Buy from Canaccord Genuity
Canaccord Genuity analyst Elyse Shapiro maintained a Buy rating on Microba Life Sciences Limited (MAP – Research Report) yesterday and set a price target of A$0.26. The company's shares closed today at A$0.15. Confident Investing Starts Here: Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter Shapiro covers the Healthcare sector, focusing on stocks such as Mayne Pharma Group, Immutep Ltd, and Neuren Pharmaceuticals Limited. According to TipRanks, Shapiro has an average return of -13.9% and a 32.84% success rate on recommended stocks. The word on The Street in general, suggests a Strong Buy analyst consensus rating for Microba Life Sciences Limited with a A$0.34 average price target.
Business Insider
15-05-2025
- Business
- Business Insider
Canaccord Genuity Remains a Hold on Mayne Pharma Group (MAYNF)
In a report released yesterday, Elyse Shapiro from Canaccord Genuity maintained a Hold rating on Mayne Pharma Group (MAYNF – Research Report), with a price target of A$7.40. The company's shares closed last Tuesday at $4.19. Confident Investing Starts Here: Quickly and easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions Receive undervalued, market resilient stocks straight to you inbox with TipRanks' Smart Value Newsletter Shapiro covers the Healthcare sector, focusing on stocks such as Mayne Pharma Group, Nanosonics Limited, and Neuren Pharmaceuticals Limited. According to TipRanks, Shapiro has an average return of -11.6% and a 35.82% success rate on recommended stocks. The word on The Street in general, suggests a Hold analyst consensus rating for Mayne Pharma Group with a $4.80 average price target.
